SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-011403 to LUDWIG ENTERPRISES, INC. (LUDG)

LUDWIG ENTERPRISES, INC.
Date: Oct. 18, 2023 · CIK: 0001960262 · Accession: 0000000000-23-011403

AI Filing Summary & Sentiment

File numbers found in text: 333-271439

Date
October 18, 2023
Author
Not clearly detected
Form
UPLOAD
Company
LUDWIG ENTERPRISES, INC.

Letter

United States securities and exchange commission logo October 18, 2023 Martin Hausman, M.D. Chief Executive Officer LUDWIG ENTERPRISES, INC. 1749 Victorian Avenue, #C 350 Sparks, Nevada 89431 Re:LUDWIG ENTERPRISES, INC. Amendment No. 5 to Registration Statement on Form S-1 Filed October 5, 2023 File No. 333-271439 Dear Martin Hausman: We have reviewed your amended registration statement and have the following comment(s). Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our October 4, 2023 letter. Amendment No. 5 to Registration Statement on Form S-1 Management, page 47 1.We note your response to comment 1 and your revised disclosure here stating that "[p]rior to his joining [y]our company as Chief Operating Officer, from July 2022 through September 5, 2022, Mr. Terwilliger, in his role as consultant to Homeopathic Partners, Inc., provided administrative services to [y]our company, under [y]our now-terminated consulting agreement with Homeopathic Partners, Inc." We also note, however, that Mr. Terwilliger is named as Incorporator and his company, Corporate World, Inc., is named as Resident Agent, in your Articles of Incorporation included as Exhibit 3.1 and dated February 8, 2006. Please clarify Mr. Terwilliger's role with your company prior to July 2022. Refer to Item 401(e)(1) of Regulation S-K.

FirstName LastNameMartin Hausman, M.D. Comapany NameLUDWIG ENTERPRISES, INC. October 18, 2023 Page 2 FirstName LastName Martin Hausman, M.D. LUDWIG ENTERPRISES, INC. October 18, 2023 Page 2 Please contact Kristin Lochhead at 202-551-3664 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters. Please contact Jessica Ansart at 202-551-4511 or Lauren Nguyen at 202-551-3642 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Eric Newlan

Show Raw Text
United States securities and exchange commission logo
October 18, 2023
Martin Hausman, M.D.
Chief Executive Officer
LUDWIG ENTERPRISES, INC.
1749 Victorian Avenue, #C 350
Sparks, Nevada 89431
Re:LUDWIG ENTERPRISES, INC.
Amendment No. 5 to Registration Statement on Form S-1
Filed October 5, 2023
File No. 333-271439
Dear Martin Hausman:
            We have reviewed your amended registration statement and have the following
comment(s).
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our October 4, 2023 letter.
Amendment No. 5 to Registration Statement on Form S-1
Management, page 47
1.We note your response to comment 1 and your revised disclosure here stating that "[p]rior
to his joining [y]our company as Chief Operating Officer, from July 2022 through
September 5, 2022, Mr. Terwilliger, in his role as consultant to Homeopathic Partners,
Inc., provided administrative services to [y]our company, under [y]our now-terminated
consulting agreement with Homeopathic Partners, Inc." We also note, however, that Mr.
Terwilliger is named as Incorporator and his company, Corporate World, Inc., is named as
Resident Agent, in your Articles of Incorporation included as Exhibit 3.1 and dated
February 8, 2006. Please clarify Mr. Terwilliger's role with your company prior to July
2022. Refer to Item 401(e)(1) of Regulation S-K.

 FirstName LastNameMartin Hausman, M.D.
 Comapany NameLUDWIG ENTERPRISES, INC.
 October 18, 2023 Page 2
 FirstName LastName
Martin Hausman, M.D.
LUDWIG ENTERPRISES, INC.
October 18, 2023
Page 2
            Please contact Kristin Lochhead at 202-551-3664 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related matters. Please
contact Jessica Ansart at 202-551-4511 or Lauren Nguyen at 202-551-3642 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Eric Newlan